We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Enanta Pharmaceuticals
ENTA
$384M
| $3.34M | 0.01% |
54,109
+3,220
| +6% | +$200K |
|
|
OSG
1502
Octave Specialty Group
OSG
$256M
| $3.34M | 0.01% |
154,638
+8,842
| +6% | +$181K |
|
|
TBI
1503
Trueblue
TBI
$301M
| $3.33M | 0.01% |
138,404
+5,218
| +4% | +$119K |
|
|
HNGR
1504
DELISTED
Hanger Inc.
HNGR
| $3.32M | 0.01% |
120,095
+69,120
| +136% | +$1.64M |
|
1505
Ares Management
ARES
$31.5B
| $3.31M | 0.01% |
92,759
+8,040
| +9% | +$250K |
|
1506
Coeur Mining
CDE
$18B
| $3.31M | 0.01% |
409,355
+35,658
| +10% | +$220K |
|
|
ZGNX
1507
DELISTED
Zogenix, Inc.
ZGNX
| $3.31M | 0.01% |
63,457
+4,097
| +7% | +$188K |
|
1508
Mercury Insurance
MCY
$6.07B
| $3.31M | 0.01% |
67,873
-1,466
| -2% | -$73.7K |
|
|
CVET
1509
DELISTED
Covetrus, Inc. Common Stock
CVET
| $3.3M | 0.01% |
250,009
+12,878
| +5% | +$156K |
|
1510
Laureate Education
LAUR
$5.24B
| $3.3M | 0.01% |
187,300
+23,869
| +15% | +$393K |
|
1511
Astec Industries
ASTE
$1.04B
| $3.29M | 0.01% |
78,371
+4,138
| +6% | +$150K |
|
1512
Alcoa
AA
$12.6B
| $3.28M | 0.01% |
152,649
-4,600
| -3% | -$95.2K |
|
|
FSP
1513
Franklin Street Properties
FSP
$48M
| $3.25M | 0.01% |
379,455
+19,593
| +5% | +$169K |
|
1514
Scansource
SCSC
$1.17B
| $3.25M | 0.01% |
87,837
+4,328
| +5% | +$147K |
|
|
AYR
1515
DELISTED
Aircastle Ltd
AYR
| $3.24M | 0.01% |
101,097
+3,057
| +3% | +$88.3K |
|
1516
United Fire Group
UFCS
$1.39B
| $3.23M | 0.01% |
73,750
+3,493
| +5% | +$156K |
|
1517
Renasant Corp
RNST
$4.03B
| $3.22M | 0.01% |
91,012
+2,663
| +3% | +$94K |
|
1518
Lattice Semiconductor
LSCC
$18.2B
| $3.2M | 0.01% |
167,391
+4,454
| +3% | +$85.5K |
|
1519
Usana Health Sciences
USNA
$277M
| $3.2M | 0.01% |
40,780
+1,264
| +3% | +$93.1K |
|
1520
First Interstate BancSystem
FIBK
$3.7B
| $3.2M | 0.01% |
76,365
+2,730
| +4% | +$114K |
|
|
RPAI
1521
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $3.2M | 0.01% |
238,520
+38,315
| +19% | +$515K |
|
|
MNDT
1522
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $3.19M | 0.01% |
193,094
+4,584
| +2% | +$73.5K |
|
|
TWO
1523
Two Harbors Investment
TWO
$1.26B
| $3.17M | 0.01% |
54,271
-613
| -1% | -$34.7K |
|
1524
Cohu
COHU
$2.45B
| $3.17M | 0.01% |
138,607
+7,333
| +6% | +$132K |
|
1525
Preferred Bank
PFBC
$1.26B
| $3.17M | 0.01% |
52,686
+1,504
| +3% | +$82.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.